<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803632</url>
  </required_header>
  <id_info>
    <org_study_id>AOL11-DR -GUILE</org_study_id>
    <nct_id>NCT02803632</nct_id>
  </id_info>
  <brief_title>Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide</brief_title>
  <acronym>ACTIHUMEUR</acronym>
  <official_title>Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide: Investigation of Disruptive Mood Dysregulation Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An excess suicide-related morbidity is observed among young people in the Picardie region, as&#xD;
      reflected by the &gt; 100% occupation rate of the Amiens University Hospital Adolescent Medicine&#xD;
      Unit&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An excess suicide-related morbidity is observed among young people in the Picardie region, as&#xD;
      reflected by the &gt; 100% occupation rate of the Amiens University Hospital Adolescent Medicine&#xD;
      Unit. New approaches have been proposed to these problems that have led us to reorganize our&#xD;
      diagnostic practices: 1) more precise characterization of suicidal behaviour by using&#xD;
      standardized instruments such as the French version of the Columbia-Suicide Severity Rating&#xD;
      Scale developed by Posner (C-SSRS); 2) new clinical entities, such as disruptive mood&#xD;
      dysregulation disorder, are now proposed in international classifications (DSM 5 field&#xD;
      trial); 3) investigations such as recording of the circadian rhythm of motor activity by&#xD;
      actigraphy are being studied as a laboratory complement to psychiatric diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    recruitment problem&#xD;
  </why_stopped>
  <start_date type="Actual">February 6, 2013</start_date>
  <completion_date type="Actual">August 24, 2018</completion_date>
  <primary_completion_date type="Actual">August 24, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)</measure>
    <time_frame>Day 0</time_frame>
    <description>The variable absence / presence of the disruptive mood dysregulation disorder (DMDD)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Suicide, Attempted</condition>
  <arm_group>
    <arm_group_label>suicide attempt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>questionnaires actigraphic recording</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <arm_group_label>suicide attempt</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>actigraphic recording</intervention_name>
    <arm_group_label>suicide attempt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children/adolescents admitted after a suicide attempt&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe depression&#xD;
&#xD;
          -  mental retardation&#xD;
&#xD;
          -  pervasive developmental disorder&#xD;
&#xD;
          -  active psychotic episode,&#xD;
&#xD;
          -  drug and alcohol abuse at the time of admission&#xD;
&#xD;
          -  organic sleep-wake disorders (sleep-related respiratory and motor disorders,&#xD;
             narcolepsy)&#xD;
&#xD;
          -  any contraindication formulated by the clinical team&#xD;
&#xD;
          -  patients not covered by French national health insurance, patients deprived of their&#xD;
             freedom as stipulated in Article L.1121-6 of the French Public Health Code&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marc GUILE, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Amiens</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AP HP</name>
      <address>
        <city>Paris</city>
        <zip>75004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 9, 2016</study_first_submitted>
  <study_first_submitted_qc>June 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 17, 2016</study_first_posted>
  <last_update_submitted>December 4, 2020</last_update_submitted>
  <last_update_submitted_qc>December 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>young</keyword>
  <keyword>disruptive mood dysregulation disorder</keyword>
  <keyword>actigraphic profile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Suicide</mesh_term>
    <mesh_term>Suicide, Attempted</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

